Dr. Hemendra J. Vekaria is a Research Assistant Professor in the Department of Neurosurgery at the Medical University of South Carolina (MUSC), with joint research involvement across neuroscience and translational brain injury programs. His research focuses on understanding how mitochondrial dysfunction and metabolic failure contribute to acute and chronic neurological disorders, particularly in neonatal intraventricular hemorrhage (IVH) and traumatic brain injury.

Dr. Vekaria earned his master’s degree and Ph.D. in Biochemistry from The Maharaja Sayajirao University of Baroda, Vadodara, India. His doctoral research investigated redox mechanisms in antibiotic-producing bacteria, and he was awarded the highly competitive Council of Scientific and Industrial Research (CSIR) Fellowship. He subsequently completed his postdoctoral fellowship under the mentorship of Dr. Patrick G. Sullivan, an internationally recognized leader in mitochondrial metabolism and brain injury research.

With over 15 years of experience in neurobiology and mitochondrial research, Dr. Vekaria has developed expertise in cellular bioenergetics, neuroinflammation, and synaptic mitochondrial function. His work has advanced understanding of how neuronal metabolic dysregulation contributes to impairments in learning, memory, and long-term neurological outcomes following brain injury. His research integrates molecular, cellular, and translational approaches to identify therapeutic strategies that target mitochondrial health and promote neuronal resilience.

Dr. Vekaria’s current research program focuses on developmental stage–specific responses to brain injury, emphasizing differences in metabolic vulnerability and inflammatory signaling between neonatal and adult brains. He is developing mitochondria-targeted therapeutic strategies designed to stimulate mitochondrial biogenesis and enhance cell-specific energy metabolism following central nervous system injury. His work bridges mechanistic discovery with translational therapeutic development to improve outcomes in vulnerable patient populations.

At MUSC, Dr. Vekaria collaborates closely with Dr. Brandon Miller, an expert in neonatal IVH, to expand institutional capabilities in central nervous system bioenergetics research and establish collaborative translational platforms focused on mitochondrial biology in developmental brain injury. He actively works with multidisciplinary teams of neuroscientists, clinicians, and translational researchers to accelerate therapeutic innovation. Dr. Vekaria is committed to mentorship and education, having trained undergraduate, graduate, and postdoctoral researchers. His long-term goal is to establish an independent research program focused on neuroenergetics and to lead collaborative initiatives advancing therapies for neurological disorders. His work has been published in more than 40 peer-reviewed scientific publications.